Yoke-eng Chiew - Publications

Overcoming intra-tumoral heterogeneity for biomarker discovery in the high-grade serous ovarian cancer proteome.

Journal: NPJ precision oncology

Published: September 19, 2024

Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

Journal: European journal of human genetics : EJHG

Published: March 22, 2022

The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.

Journal: Nature genetics

Published: January 06, 2022

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 25, 2021

DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: May 27, 2021

Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

Journal: European journal of human genetics : EJHG

Published: December 07, 2020

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 11, 2020

Therapeutic options for mucinous ovarian carcinoma.

Journal: Gynecologic oncology

Published: October 09, 2019

The molecular origin and taxonomy of mucinous ovarian carcinoma.

Journal: Nature communications

Published: December 11, 2018

BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition.

Journal: JCO precision oncology

Published: November 01, 2018

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.

Journal: Scientific reports

Published: September 26, 2017

Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 08, 2017